Novotech’s Post

🌐 Exciting News in the World of Healthcare! 🌟 Today, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. proudly announces the successful acquisition of a controlling 75% stake in Germany-based DiaSys Diagnostic Systems GmbH. 🤝💼 🚀 Mindray is thrilled to welcome DiaSys into their group, marking a significant milestone in our global expansion journey. This strategic move allows us to expedite the development of our overseas supply chain platform, access a talented international team, and enhance our In-vitro diagnostics offering. 💡🌍 👏 "We are delighted to welcome DiaSys as a member of the Mindray family! Mindray is committed to offering resources and support to DiaSys while leveraging our extensive experience in global integration to achieve effective synergistic growth for both companies," says Wu Hao, President of Mindray. 🌐🔬 🌟 Dr. Günther Gorka, Founder of DiaSys, shares the excitement, "We are thrilled by being now a part of Mindray and being able to enhance the capabilities and expand the global footprint of both parties involved! Both companies will support each other to optimize market coverage in the future together." 🌐🌐 🤝 Upon completion of the transaction, DiaSys will seamlessly integrate into Mindray's system. A unified team will work closely to enhance products, facilitate joint development, expand platforms, and execute the DiaSys integration plan orderly and smoothly. This strategic alignment aims to substantially strengthen Mindray's global competitive edge in the In-vitro diagnostics business. 💪🔬 🔗 #Mindray #DiaSys #HealthcareInnovation #GlobalExpansion #MedicalTechnology #MergersAndAcquisitions #InVitroDiagnostics #CollaborationForGrowth 🌐🌟

Further acquisitions in the CRO space as Tigermed acquire NAMSA China

☀️Unlock Your Path to Italian Market Success with Our Expertise! With over 20 years of experience, we've been at the forefront of guiding MedTech innovators and regulatory professionals toward successful registrations and global market access. Our proven track record includes helping industry leaders like VAREX Imaging, PAMPAMED, Global Instrumentation and HUAWEI streamline their product registrations in Italy. Ready to Accelerate Your Italian Market Entry? Let us help you navigate the complex regulatory landscape and expedite your path to success. Where to next? Discover how we can support your journey: https://hubs.ly/Q02Kk4VW0 #ArazyGroup #Regtech #RegtechAI #Medtech #RegulatoryAffairs #ProductRegistration #ItalyMarketAccess #GlobalMarketAccess #MedTechInnovation #ComplianceExcellence #CEMarking

☀️Unlock Your Path to Italian Market Success with Our Expertise! With over 20 years of experience, we've been at the forefront of guiding MedTech innovators and regulatory professionals toward successful registrations and global market access. Our proven track record includes helping industry leaders like VAREX Imaging, PAMPAMED, Global Instrumentation and HUAWEI streamline their product registrations in Italy. Ready to Accelerate Your Italian Market Entry? Let us help you navigate the complex regulatory landscape and expedite your path to success. Where to next? Discover how we can support your journey: https://hubs.ly/Q02KjVRQ0 #ArazyGroup #Regtech #RegtechAI #Medtech #RegulatoryAffairs #ProductRegistration #ItalyMarketAccess #GlobalMarketAccess #MedTechInnovation #ComplianceExcellence #CEMarking

☀️Unlock Your Path to Italian Market Success with Our Expertise! With over 20 years of experience, we've been at the forefront of guiding MedTech innovators and regulatory professionals toward successful registrations and global market access. Our proven track record includes helping industry leaders like VAREX Imaging, PAMPAMED, Global Instrumentation and HUAWEI streamline their product registrations in Italy. Ready to Accelerate Your Italian Market Entry? Let us help you navigate the complex regulatory landscape and expedite your path to success. Where to next? Discover how we can support your journey: https://hubs.ly/Q02KkHNL0 #ArazyGroup #Regtech #RegtechAI #Medtech #RegulatoryAffairs #ProductRegistration #ItalyMarketAccess #GlobalMarketAccess #MedTechInnovation #ComplianceExcellence #CEMarking

Meet with Olga Ivanova, our Business Development Director at BIO KOREA 2024! Let us discuss the latest technology trends and how they can support your clinical trial success. From regulatory strategies to our unique Accelerant methodology, we’ll give you insights on how you can conduct your clinical studies on a global scale. Grab this chance to learn how our Functional Services (FSP) can advance your trial implementation. We’re looking forward to meeting you! #clinicalresearch #clinicaltrials #BIOKOREA #BK2024 #바이오코리아

How did a leading medical device manufacturer in China increase its MSCI rating from 'BB' to 'AA'? In this success story, we highlight why active engagement with our investee companies is important and how the engagement can benefit the investors too. Keen to know more? Read on how abrdn uses its voting power to make a difference: https://lnkd.in/gYQjYVHX Unlock Asia's potential with abrdn today: https://lnkd.in/gUDBR3DV Investment involves risk. #abrdnInAsia

📊 💡Join our upcoming webinar with Taimei Technology to delve into the promising collaboration between China and Australia in the clinical trial and biotech sectors! The expert speakers will highlight how dynamics between sites, investigators, and recruitment strategies vary across different therapy areas. Understanding these nuances is crucial for optimizing clinical trial outcomes. Through expert insights and case studies, attendees will learn practical recommendations and best practices for maximizing collaboration and ensuring successful clinical trials in Australia. ➡️ More info and registration here: https://buff.ly/3Jic3oB 🌟 Expert speakers: Tam C. Nguyen Robert Lin, MBA Nate Zhang Lisa Nelson #ClinicalTrials #ClinicalResearch #PatientRecruitment #ClinicalOperations #ClinicalSites #ClinicalTrialsAustralia #Commercialization #MarketAccess #CTLogistics

I am very much looking forward to interesting discussions. Are you wondering how you can reduce the high costs of your internal compound logistics? Have you ever thought about spreading the high running costs over several shoulders by outsourcing? If you would like to discuss the possibilities, please contact me by email or book an timeslot at SLAS.

The region of Southeast Asia (SEA) is a significant emerging market for industries, including medical technologies (MedTech) industries. As with many other industries, MedTech strongly relies on computer implementations as these provide numerous advantages. In part two of this two-part series, Patent Engineer Martina Barbiero and Principal Nicholas Lakatos, look at specific real-life examples of patent applications in the hub of SAE, Singapore, and draw comparisons to how the same technologies are treated in Australia with respect to patentable subject matter. Read part two here: https://lnkd.in/gMu8UUjC Last week, we released part one in this two-part series that examined if it is possible to meet patentable subject matter requirements in the key countries in SEA for computer implemented medical technologies. Read part one here: https://lnkd.in/gq-ih6vS